Diagnostic formulation #
ICD-11 describes a concurrent psychotic and mood syndrome. Reconstruct the relationship between the syndromes within the episode, rather than adding together two diagnoses from unrelated encounters. The longitudinal DSM approach differs; record which classification is being applied instead of assuming the labels are interchangeable.
Targeted assessment #
Obtain dated examples of delusions, hallucinations, disorganisation, mood elevation, depressed mood, energy, sleep and function. With consent, compare these with collateral and previous records. Establish whether apparent depression reflects a depressive episode, negative symptoms, sedation or distress about psychotic experiences.
Important alternatives #
Distinguish mood disorder with psychotic features, schizophrenia with mood symptoms, substance-induced illness and secondary psychosis. Do not decide solely from whether the delusions seem congruent with mood. A fluctuating level of attention or consciousness requires an independent medical assessment.
Investigations and physical assessment #
The examination and exposure history should identify possible secondary causes of the combined syndrome. Separate investigations aimed at explaining the presentation from baseline checks for a proposed medicine. New neurological findings, intoxication, dehydration or impaired consciousness change the urgency and scope of assessment.
Treatment and recovery #
Plan treatment for the established psychotic and mood components together. A psychosis guideline alone does not establish the appropriate treatment of mania or depression. Record the rationale and indication for every medicine, and coordinate psychological, family and functional support.
Doses & prescribing #
Each prescribing record identifies its population and source jurisdiction; international labeling does not establish Indian approval. The clinician selects treatment after assessment.
No category-specific dose schedule has been verified for this chapter. General psychosis guidance is not sufficient to choose a drug, formulation or dose.
When progress is limited #
Review whether both components were actually measured and treated. Examine exposure, adherence, adverse effects and episode chronology before concluding that the condition is resistant. A persistent label can obscure an evolving bipolar or schizophrenia-spectrum formulation.
Continuing care and discontinuation #
Base continuing care on previous episodes, their consequences, response and adverse effects. Explain which treatment addresses which part of the illness. Any reduction needs an individual prescriber plan and monitoring of both mood change and psychosis; no universal discontinuation schedule follows from the label.
Age and population considerations #
For adolescents, obtain developmental and educational history and use child-specialist assessment. In older adults with new symptoms, give particular attention to cognitive change, neurological illness and medicines. Perinatal onset requires a prompt specialist assessment of mood, psychosis and the practical care situation.
Follow-up priorities #
Track mood episodes, psychotic symptoms, sleep, functioning and treatment burden separately. A fall in hallucination severity does not establish recovery from depression or mania. Agree early warning signs and a route to reassessment, including when the person is less able to seek help.
Clinical pitfalls #
Do not infer schizoaffective disorder from a problem list containing both schizophrenia and depression. Preserve uncertainty when contemporaneous observations are unavailable. Diagnostic clarification must not delay treatment of urgent clinical needs.
Current guidance context #
NICE general psychosis guidance informs specialist assessment and coordinated care; it does not supply a disorder-specific prescribing schedule for this chapter. Child and adolescent assessment follows a separate specialist pathway.
Assessment tools #
Choose the instrument for its intended purpose; interpretation accompanies the linked tool.
Patient discussion #
Open a plain-language explanation
We will look at changes in mood and experiences together, including when each started. The treatment plan can change as the pattern becomes clearer.
Related terminology #
Search terms: schizoaffective psychosis. These terms may differ between classifications; the diagnostic formulation above explains the chapter scope.
References · 4
- WHO ICD-11 CDDR (2024), Schizoaffective disorder · International; classification reference · Checked 2026-10-31 · PDF pages 188, 189, 190, 191, 192, 193, 194 · Printed/visible pagination 170-176 · Supports: Diagnostic formulation; Important alternatives; Age and population considerations; Clinical pitfalls
- NICE CG178, psychosis assessment and care; extrapolation where stated · United Kingdom; general psychosis guidance, not a category-specific protocol · Checked 2026-10-31 · Supports: Current guidance context
- NICE CG155, child and adolescent psychosis assessment · United Kingdom; child-specialist care · Checked 2026-10-31 · Supports: Age and population considerations; Current guidance context
- Semple and Smyth, Oxford Handbook of Psychiatry, 4th edition (2019), Schizophrenia and related psychoses · United Kingdom; older educational text, current checks listed separately · Checked 2026-10-31 · PDF pages 204, 207, 221, 222 · Printed/visible pagination Reflowed document visible pagination: 203, 206, 220, 221 · Supports: Targeted assessment; Investigations and physical assessment; Treatment and recovery; When progress is limited; Continuing care and discontinuation; Follow-up priorities
